SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Church who wrote (284)2/13/1997 4:45:00 PM
From: Pete Holm   of 6136
 
Maybe not the closest parallel, but look at Vivus. I think they got approval for their impotency therapy just before the first of the year. The stock spiked to 43, then pulled back to about 36 for a couple of weeks. It got as high as 69 today.

If you sell AGPH at 250, save your money for therapy. You'll need it when the stock hits 600. I heard a rumor that when they give their new employees stock options, they are telling them that the stock will be at this level by 2004.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News